Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Efficacy of Upright MP - MRI for Prostate Cancer Screening

NCT03474913 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT03474913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03474913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Efficacy of Upright MP - MRI for Prostate Cancer Screening
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2018
Completion date
July 1, 2026
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elevated prostate specific antigen, elevated psa, prostate cancer